Skip to main content
. Author manuscript; available in PMC: 2018 May 1.
Published in final edited form as: J Pediatr. 2017 Feb 16;184:157–164.e2. doi: 10.1016/j.jpeds.2017.01.017

Table 1.

Genetic Disorders of Surfactant Metabolism

Surfactant Protein B Deficiency ABCA3 Deficiency Neonate ABCA3 Deficiency Infant ABCA3 Deficiency Child Surfactant Protein C Associated Lung Disease NKX2-1 Deficiency Neonate NKX2-1 Deficiency Child
Presentation Acute severe neonatal respiratory distress (RDS) shortly after birth5 Acute severe neonatal RDS shortly after birth35 Respiratory distress or interstitial lung disease (chILD) between 1month and 1 year35 Interstitial lung disease (chILD) after 1 year of life35 Interstitial lung disease (chILD) and/or failure to thrive during infancy and childhood; less commonly as neonatal RDS10 Acute severe neonatal RDS shortly after birth, hypothyroidism, hypotonia16 Interstitial lung disease (chILD), recurrent respiratory infections, chorea, ataxia, developmental delay, hypothyroidism16
Frequency 1 per million European-descent (ED)4 As frequent as 1/3100 ED; as frequent as 1/18,000 African-descent (AD)13 As frequent as 1/3100 ED; as frequent as 1/18,000 AD13 As frequent as 1/3100 ED; as frequent as 1/18,000 AD13 Unknown4 Unknown16 Unknown16
Disease Course Lethal in newborn period5 Lethal for infants with 2 loss of function (frameshift, nonsense) mutations, variable for other genotypes35 Variable35 Variable35 Variable22 Variable16 Variable16
Inheritance Recessive/compound heterozygous Recessive/compound heterozygous Recessive/compound heterozygous Recessive/compound heterozygous Dominant, sporadic Dominant, sporadic Dominant, Sporadic